M Al Azzawi, C Drumm, C Cullinane, C Manole, A Coffey, D O'Neill, C O'Sulleabhain, A O'Sullivan, T Murphy
{"title":"Cholecystostomy Drainage - Current Practices in a Tertiary Hepatobiliary Unit.","authors":"M Al Azzawi, C Drumm, C Cullinane, C Manole, A Coffey, D O'Neill, C O'Sulleabhain, A O'Sullivan, T Murphy","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acute calculous cholecystitis (ACC) is a common general surgical emergency and accounts for 20% of symptomatic gallstone presentations. According to the Tokyo Guidelines, severe ACC necessitates cholecystostomy drainage. Percutaneous Cholecystostomy Drains (PCD) are a temporary intervention in acutely unwell patients with gallbladder-related disease who are unfit to undergo surgery. PCD is used with a therapeutic or palliative intent for the management of gallbladder disease based on the condition and the patient's fitness. This study aims to assess the current role of PCDs in a tertiary hepatobiliary referral centre.</p><p><strong>Methods: </strong>This was a retrospective review of PCD patients treated in a tertiary hepatobiliary referral centre between January 2018 and December 2023. Clinical, radiological, and perioperative outcomes were measured. Descriptive analysis was performed using GraphPad Prism.</p><p><strong>Results: </strong>Sixty-eight patients were identified over six years. The mean age was 71.6 years, with a male majority. The most common diagnosis was severe cholecystitis with septic shock (23, 33.8%), followed by gallbladder perforation (18, 26.4%). The mean duration of PCD placement was 95.78 days. A post-drainage cholecystectomy was performed in 7 (87.1%) of patients with ASA I-II and 24 (40%) with ASA III-IV (p-value<0.05).</p><p><strong>Conclusions: </strong>PCDs are safe and effective in managing surgically unfit patients with severe, complicated ACC. There is a paucity of literature on specific guidelines for the indications, follow-up, and management of PCDs.</p>","PeriodicalId":14713,"journal":{"name":"Irish medical journal","volume":"119 8","pages":"158"},"PeriodicalIF":0.0000,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Irish medical journal","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Acute calculous cholecystitis (ACC) is a common general surgical emergency and accounts for 20% of symptomatic gallstone presentations. According to the Tokyo Guidelines, severe ACC necessitates cholecystostomy drainage. Percutaneous Cholecystostomy Drains (PCD) are a temporary intervention in acutely unwell patients with gallbladder-related disease who are unfit to undergo surgery. PCD is used with a therapeutic or palliative intent for the management of gallbladder disease based on the condition and the patient's fitness. This study aims to assess the current role of PCDs in a tertiary hepatobiliary referral centre.
Methods: This was a retrospective review of PCD patients treated in a tertiary hepatobiliary referral centre between January 2018 and December 2023. Clinical, radiological, and perioperative outcomes were measured. Descriptive analysis was performed using GraphPad Prism.
Results: Sixty-eight patients were identified over six years. The mean age was 71.6 years, with a male majority. The most common diagnosis was severe cholecystitis with septic shock (23, 33.8%), followed by gallbladder perforation (18, 26.4%). The mean duration of PCD placement was 95.78 days. A post-drainage cholecystectomy was performed in 7 (87.1%) of patients with ASA I-II and 24 (40%) with ASA III-IV (p-value<0.05).
Conclusions: PCDs are safe and effective in managing surgically unfit patients with severe, complicated ACC. There is a paucity of literature on specific guidelines for the indications, follow-up, and management of PCDs.
期刊介绍:
Since its inception in 1867, the Journal of the Medical Association of Ireland and now in its present format, the Irish Medical Journal, has provided the medical community in Ireland with an invaluable service. As one of the leading biomedical publications in Ireland, it has sought to continue the education of medical students and postgraduates through scientific research, review articles and updates on contemporary clinical practices while providing an ongoing forum for medical debate. A measure of our stature is that we are listed in the Index Medicus and issued annually with a citation factor from the Institute for Scientific Information.